All Stories

AI and data ownership reshape pharma marketing: DeepIntent’s Jay Richetelli weighs in

DeepIntent’s Jay Richetelli discusses the role of AI, data ownership and trust in shaping the next era of pharma marketing

Jun 2, 2025 - 13:35
 0
AI and data ownership reshape pharma marketing: DeepIntent’s Jay Richetelli weighs in
DeepIntent’s Jay Richetelli discusses the role of AI, data ownership and trust in shaping the next era of pharma marketing
Read More

Tags:

Previous Article

GCI Health’s Kristin Cahill talks health communications, misinformation and medi...

Next Article

AI, personalization and privacy: Inmar’s vision for the future of pharma marketing

Related Posts

Fierce Pharma Asia—Pfizer's PD-1xVEGF bet; An Alzheimer's blood test approval; Samsung's biosim spinoff

Fierce Pharma Asia—Pfizer's PD-1xVEGF bet; An Alzheimer...

May 23, 2025  0

Sanofi eyes vaccine manufacturing in Vietnam amid tech transfer with local firm

Sanofi eyes vaccine manufacturing in Vietnam amid tech ...

May 27, 2025  0

ASCO: AstraZeneca looks to bring immunotherapy to early-stage stomach cancer with Imfinzi

ASCO: AstraZeneca looks to bring immunotherapy to early...

Jun 1, 2025  0